This document discusses and compares several drugs used to treat hypertension, including both local and general hypertension. It focuses on bosentan, valsartan, candesartan, taldenafil, and ambrisentan. Powerful text mining tools are used to extract key concepts about the effects of these drugs from scientific literature in seconds. The tools can also identify applications, market presentations, and patent information about these drugs.

1. A comparison of hypertension
managers
An approach of neophytes using text
mining powerful tools

2. Despite there are some habits that help to
manage hypertension, as the DASH diet, lose of
weight, etc , this report will focus on several
drugs aiming to manage hypertension, be it
local (pulmonary, kidney, etc) or general.
As neophytes we need the help of powerful text
mining tools to be able to extract key concepts
as effects, or new market opportunities, also
some knowledge networks, in a very short
time*, complementing the chemistry
information
(*) More on this in other triz XXI slideshare presentations

3. Bosentan
Effects of some hypertension drugs
Valsartan Candesartan
The numbers reflect how many instances of these
effects have been found in thousands of full articles,
patents, ebooks, pubmed, proceedings and web pages

4. Taldenafil Ambrisentan Bosentan
Effects of some pulmonary hypertension drugs
Just introducing the word bosentan we obtain all
effects extracted from scientific, technologic and
market unstructured text sources in seconds

5. Market Opinions
about Bosentan

6. Market Opinions
about Valsartan

7. Market Opinions
about
Candesartan

8. Some
Bosentan
Applications
Configurations in the market
Our tools are
able to read
an article, a
document and
identify where
and why
bosentan drug
is used.
Likewise are
able to
identify
different
parameters as
market
presentations

9. Some
Ambrisentan
Applications
Configurations in the market
Our tools are
able to read
an article, a
document and
identify where
and why
ambrisentan
drug is used.
Likewise are
able to
identify
different
parameters as
market
presentations

10. In a second, who is
who in claiming rights
about the Bosentan
and what pace they
show
(citing bosentan in the
claims of the patent
documents)

12. of chronic hypoxia
Maybe we want to explore, in seconds, other causes for pulmonary
hypertension … … …… …of Pulmonary hypertension

13. of Pulmonary hypertension
of chronic hypoxia
Maybe we want to explore other causes for pulmonary hypertension …
… …… … and in a minute, its cause’s causes

14. of Pulmonary hypertension
of chronic hypoxia
Maybe we want to explore other causes for pulmonary hypertension …
… …… … and in a second, its cause’s causes
So you may better treat your snoring or
apnea before you get a chronic hypoxia which
may lead to a pulmonary hypertension
APNEA  CHRONIC HYPOXIA  PULMONARY HYPERTENSION  BOSENTAN

15. Thanks for your time
For more info please contact
Triz XXI
informa@triz.es